Skip to main content
SpringerLink
Log in

Reduced anti-TNF dosing strategy proves cost saving in AS

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Zavada J, et al. A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study. Annals of the Rheumatic Diseases : 27 Aug 2014. Available from: URL: http://doi.org/10.1136/annrheumdis-2014-205202

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reduced anti-TNF dosing strategy proves cost saving in AS. PharmacoEcon Outcomes News 711, 28 (2014). https://doi.org/10.1007/s40274-014-1537-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1537-0

Search

Navigation